Written by Ad OpsOverview and Naming
Medical Glue is a hybrid cannabis cultivar created by the Las Vegas–based breeder Sin City Seeds, a group known for resin-forward crosses and robust production traits. The strain name signals two things at once: medical-grade relief and the sticky, resinous ‘glue’ character that defines the Glue family. Its recorded heritage is indica/sativa, reflecting a balanced genetic strategy meant to deliver both body-centric calm and clear-headed functionality. In practice, consumer reports often describe it as versatile enough for daytime microdosing and evening relaxation when taken at higher doses.
As with many Glue-associated cultivars, Medical Glue emphasizes dense trichome coverage and strong aromatic output, both of which point to elevated terpene and cannabinoid content. The breeder’s reputation suggests a focus on stability, vigor, and resin production, traits that support both medical use and commercial-scale cultivation. While specific breeding notes for Medical Glue are limited in the public domain, Sin City Seeds’ portfolio consistently demonstrates a preference for hybrid vigor and manageable flowering times. The result is a cultivar designed to satisfy patients seeking consistent potency alongside growers who value reliability.
The strain’s positioning in the marketplace also reflects an emphasis on efficacy per gram, a metric important to both medical patients and cost-conscious consumers. Glue-type cultivars commonly test in the high-teens to mid-20s for THC, providing a benchmark for expected potency. That profile is compatible with a broad range of delivery methods, from flower and pre-rolls to solventless concentrates. Medical Glue’s branding thus connects legacy Glue performance to contemporary medical needs.
History and Breeding Background
Sin City Seeds emerged in the early 2010s and quickly earned recognition for crosses that amplify resin density, terpene richness, and reliable structure. Their catalog includes numerous hybrids tuned for both commercial performance and patient utility, a dual mandate that shapes Medical Glue’s identity. While the precise parentage of Medical Glue is not widely published, Sin City Seeds’ track record suggests deliberate selection for frost-laden flowers, easy-to-train architecture, and above-average potency. The indica/sativa designation aligns with the breeder’s typical approach: hybrids that avoid extremes and remain adaptive across contexts.
The Glue family’s broader history informs Medical Glue’s intent. Original Glue (often called GG4) rose to prominence in the mid-2010s for its heavy resin and unmistakable gas-diesel profile, setting a standard for stickiness and couch-lock potential at higher doses. Many modern Glue hybrids borrow these characteristics while tempering intensity with brighter, more functional top-notes. In this lineage context, Medical Glue can be understood as a purposeful hybridization aimed at medical-grade relief without sacrificing flavor complexity or bag appeal.
Breeders who work in the Glue space often select for uniform internodal spacing, high calyx-to-leaf ratios, and robust trichome heads suitable for mechanical or ice-water separation. Medical Glue’s brand narrative fits this mold, implying good performance in both flower and concentrate formats. Anecdotal grower reports on comparable Glue hybrids cite flowering windows around 8–10 weeks and yields that scale well with training. Those benchmarks provide a practical frame of reference for Medical Glue’s cultivation and harvest expectations.
Given Sin City Seeds’ reputation and the strain’s naming, Medical Glue was likely positioned to serve patients seeking repeatable symptom relief and cultivators who want predictable garden outcomes. Growers often associate Sin City Seeds with consistent germination rates and vigorous early growth, valuable traits for hobbyists and professionals alike. The breeder’s focus on resin potential ensures Medical Glue can compete in an increasingly concentrate-aware market. These historical factors shape both consumer expectations and cultivation strategies.
Genetic Lineage and Phenotypic Expectations
Medical Glue is categorized as an indica/sativa hybrid, indicating a balanced chemotype that toggles between mental clarity and body relaxation. While its exact parent lines are not publicly confirmed, Glue-family hybrids frequently descend from genetics that include Chem- and Diesel-related ancestors. Those backgrounds are known for their high-THC potential, fuel-forward aroma, and robust trichome coverage that lends itself to a classic sticky feel. Medical Glue is expected to inherit a similar cannabinoid and terpene footprint, optimized by Sin City Seeds’ selection.
Phenotypically, plants in the Glue category often display medium internodal spacing, strong lateral branching, and a sturdy central leader. Growers can typically coax a symmetrical canopy with topping and low-stress training, encouraging multiple colas of uniform size. The calyx-to-leaf ratio tends to be favorable, which simplifies trimming and improves post-harvest labor efficiency. With proper nutrition and environment, the phenotype expresses thick trichome carpets that shimmer silver-white by late flower.
Chemotypically, Glue-style hybrids routinely test in the 18–26 percent THC range under competent cultivation, with minor cannabinoids like CBG registering between 0.1–0.8 percent. CBD is usually minimal, often below 1 percent, although trace amounts can slightly modulate perceived intensity. Total terpene content commonly falls between 1.5–3.5 percent by dry weight, or roughly 15–35 mg per gram of cured flower. Myrcene, beta-caryophyllene, limonene, humulene, and alpha-pinene are frequent primary contributors.
For Medical Glue specifically, these expectations translate into a strain likely to be forgiving in the garden and impressive in the jar. Moderate node spacing helps light penetrate deeper into the canopy, improving bud sites below the top layer. Resin-headed trichomes tend to be plentiful and mechanically resilient, an advantage for solventless extraction yields. The overall phenotype profile suits growers seeking both flower sales and concentrate inputs from the same harvest.
Appearance and Bud Structure
Buds of Medical Glue are expected to be medium to large with a compact, slightly conical structure that tightens as they cure. A hallmark visual feature is the heavy frosting of bulbous trichome heads that lend the flowers a pale, silvery sheen. Pistils typically mature from pale orange to amber, offering warm contrast against olive-to-lime green bracts. Under magnification, capitate-stalked trichomes appear densely spaced and uniform, often signaling high resin content.
The calyx-to-leaf ratio tends to run favorable, commonly around what growers informally describe as 2.5–3:1 in Glue-type hybrids. That ratio supports faster trimming times and attractive, sculpted nugs after a careful hand manicure. Bract density and tight stacking give the cultivar substantial weight in the hand despite moderate overall size. Proper curing preserves structure while enhancing gloss as terpenes re-equilibrate in the jar.
Visually, Medical Glue dried flowers are often described as photogenic, especially when processed under consistent environmental controls. Light green hues dominate, with darker sugar leaves removed to highlight the resin-drenched calyxes. When broken apart, the interior often reveals glassy trichome heads intact on the bract surfaces, a positive indicator for solventless pressing. In aggregate, the bud structure signals both potency and quality, aligning with patient expectations for a medical-branded Glue.
Aroma and Nose Profile
Medical Glue projects the classic Glue family aromatic theme of gas, rubber, and earthy-pine, punctuated by brighter citrus or herbal accents depending on phenotype. The top notes frequently suggest diesel and a faintly solvent-like character reminiscent of fresh adhesive, though of course no actual solvents are present. Beneath that, a woody, peppery backbone likely driven by beta-caryophyllene and humulene provides depth and structure. Many noses also pick up sweet cocoa or coffee hints that can bloom after grinding.
As the jar breathes, monoterpenes like limonene and myrcene tend to volatilize quickly, shifting the aroma from sharp to rounded within a few minutes. This evolution is typical of terpene-rich flowers, where lighter compounds flash off first while heavier sesquiterpenes linger. After grinding, the aromatic intensity often increases by 20–30 percent subjectively due to greater surface area and terpene release. Airtight storage and cooler temperatures help preserve the initial bouquet for months.
Measured across Glue-family cultivars, total terpene content commonly lands in the 1.5–3.5 percent range by weight, which equates to 15–35 mg of volatile aroma compounds per gram of flower. In practice, this means Medical Glue can fill a room quickly when the jar is opened, especially with fresh cures. The precise nose will vary slightly between phenotypes and batches, but the common denominator is assertive and unmistakable. For many patients, the aroma itself is a proxy for expected potency and relief.
Flavor and Consumption Experience
On inhalation, Medical Glue typically delivers a first impression of fuel and pine that lands squarely on the tongue and roof of the mouth. Exhale often introduces a peppery-sweet twist with faint cocoa, carrying a dry, woody finish. Vaporization at moderate temperatures tends to emphasize citrus and herbal tones while retaining the diesel core. In joints or pipes, combustion can bring forward the peppery caryophyllene edge.
Temperature management is key to flavor fidelity. Many connoisseurs target 175–190 C for flower vaporization to preserve volatile monoterpenes like limonene and myrcene while still activating THC. Those seeking the full spectrum, including heavier sesquiterpenes such as caryophyllene and humulene, may prefer a range of 195–205 C. Above ~210 C, flavor can turn harsh as thermal degradation increases, even though effect intensity may rise.
In concentrate form, Medical Glue’s resinous character lends itself to terpene-forward dabs that highlight gas-diesel clarity. Solventless rosin produced from well-grown flowers often retains pine and lemon highlights, while hydrocarbon extracts can capture deeper coffee and earthy tones. Because the strain tends to be terpene-rich, small dose sizes may still deliver robust flavor and noticeable onset. Users often report that flavor intensity correlates with cure quality and storage conditions.
Cannabinoid Profile and Potency
While specific, peer-verified lab panels for Medical Glue are limited in public archives, Glue-family data provide a reliable reference. Under competent cultivation and curing, THC content frequently ranges between 18–26 percent by dry weight, with outliers reported above 28 percent in high-performance runs. At 20 percent THC, a single gram contains roughly 200 mg of THC, a relevant calculation for both dosing and extraction planning. CBD content is typically minimal, often 0–1 percent, and CBG commonly appears in the 0.1–0.8 percent range.
Minor cannabinoids like CBC and THCV may be present in trace amounts, generally under 0.2 percent for THCV in Glue-leaning phenotypes. Although minor by weight, these compounds can subtly modulate the qualitative experience through entourage effects. For example, CBG has been investigated for anti-inflammatory and neuroprotective potential, while CBC is studied for mood and pain interactions. The exact contributions remain an area of active research.
From a patient standpoint, potency dictates dose sizing. For inhalation, many new users begin with 2–5 mg THC per session, which, at 20 percent THC flower, corresponds to roughly 1–2 puffs depending on device efficiency. Experienced users may titrate to 10–20 mg THC in a session for more pronounced relief, especially for evening use. Oral routes deliver longer duration but slower onset, with 1–2.5 mg THC considered a low starting dose for naive patients and 5–10 mg a common intermediate range.
Lab transparency matters for medical planning. Patients and clinicians benefit from Certificates of Analysis (COAs) that report full cannabinoid and terpene panels along with batch dates and testing methods. Total active cannabinoids and total terpenes together predict much of the experience intensity and flavor. For Medical Glue, look for total terpene values above 1.5 percent and THC above 18 percent as practical quality markers.
Terpene Profile and Minor Volatiles
Medical Glue is likely dominated by a caryophyllene–myrcene–limonene axis, mirrored across many Glue-family cultivars. In composite Glue-type COAs, myrcene frequently registers around 0.4–1.2 percent by weight, with beta-caryophyllene often 0.3–0.9 percent and limonene 0.2–0.8 percent. Humulene and alpha-pinene commonly contribute in the 0.05–0.3 percent range each, rounding out the woody and piney notes. Total terpene content of 1.5–3.5 percent is a practical expectation for well-grown batches.
Beta-caryophyllene is notable as a dietary cannabinoid that binds to CB2 receptors, potentially influencing inflammation signaling. Myrcene has been associated with earthy-fruity aromas and is frequently discussed in relation to perceived sedation at higher doses. Limonene is linked with bright citrus notes and may support mood-elevating qualities in some users. Pinene is often discussed for its potential to counter short-term memory fog via acetylcholinesterase inhibition, though clinical evidence is still emerging.
Minor compounds like linalool, ocimene, and nerolidol may appear in trace-to-moderate quantities depending on phenotype and environmental factors. Linalool can add lavender-like softness and is commonly associated with calming properties. Ocimene contributes a green, slightly sweet herbal facet and is sometimes noted for decongestant perceptions. Nerolidol, a sesquiterpene, brings woody-floral nuance and is studied for skin permeability effects.
Environmental controls influence terpene expression as much as genetics. Lower late-flower temperatures, gentle airflow, and careful handling preserve monoterpenes that otherwise volatilize easily. Post-harvest, target a slow dry at approximately 60–65 percent relative humidity and 60–64 F to retain aromatic integrity. Properly cured Medical Glue should perfume a room on opening while leaving a long tail of diesel-pine complexity.
Experiential Effects and Use Dynamics
Medical Glue, as a balanced indica/sativa hybrid from Sin City Seeds, tends to produce a two-phase experience: an initial uplift followed by full-body calm. Inhalation onset is typically felt within 1–3 minutes, peaks by 10–20 minutes, and sustains for 60–120 minutes depending on dose. A low-dose session can feel clear and task-compatible, especially for users with tolerance. Higher doses tilt toward tranquil body heaviness, with some reports of couch-lock when exceeding 15–20 mg THC in a single sitting.
Cognitive effects often include a soft mental quieting and reduced rumination, valuable for stressed or anxious states. The physical layer may feature loosened muscle tension and dampened pain signaling, common goals among medical users. As with many Glue derivatives, the strain can be sedating late in the day, particularly when taken after prolonged activity. The qualitative profile aligns with evening wind-down routines and low-stimulation activities.
Duration varies by route. Vaporized flower wears off faster than edibles but allows precise, moment-to-moment titration. Edibles provide a longer arc of 4–8 hours for many users, with an onset of 45–120 minutes and a peak around 2–3 hours. This extended tail can be beneficial for sleep maintenance but requires conservative first-time dosing.
Set, setting, and hydration matter. A calm environment reduces the chance of racing thoughts at onset, and adequate fluids help counter cottonmouth. Nutrition timing can temper the intensity of oral doses by slowing absorption. Users sensitive to THC may benefit from pairing with CBD-dominant products to moderate peaks.
Potential Medical Applications
The name Medical Glue reflects its positioning for symptom relief across common patient concerns. Survey data from multiple state medical programs consistently shows chronic pain as the leading indication, often cited by 60–70 percent of enrolled patients. For this use case, THC-driven analgesia combined with caryophyllene’s CB2 activity and myrcene’s body heaviness provides a plausible mechanism for perceived relief. Patients frequently describe reductions in pain scores and improved tolerance for daily activities after titrated dosing.
Anxiety and stress are additional targets, where limonene’s bright affect and low-to-moderate THC doses may help reduce tension without overwhelming sedation. In practice, patients report that 2–5 mg inhaled THC equivalents can take the edge off situational anxiety while preserving function. For those prone to THC-induced anxiety, pairing Medical Glue with CBD-rich products or microdosing during the day can minimize jitteriness. A slow approach, with careful journaling of dose and context, improves outcomes.
Sleep initiation and maintenance represent another frequent use. Glue-type hybrids often support sleep at doses that exceed functional daytime thresholds, with many users finding 5–10 mg oral THC effective for falling asleep. For maintenance insomnia, the 4–8 hour duration of edibles can help sustain rest, though next-day grogginess is a risk at higher doses. Patients should start low and adjust in small increments over several nights.
Muscle spasm and tension relief are commonly reported benefits with Glue hybrids. The body-centered relaxation and perceived reduction in spasticity can improve mobility windows for physical therapy or home exercise routines. Some users also cite relief from migraine frequency or intensity, though responses vary widely and triggers must be considered. As always, cannabis should complement, not replace, physician-guided care plans.
Nausea and appetite support round out the frequent indications list. THC’s antiemetic effect is well-documented in chemotherapy-related protocols, and even low inhaled doses can quickly reduce queasiness for some patients. Appetite stimulation often follows, helping those with poor intake maintain weight. Patients should discuss cannabis use with their care teams, especially if taking medications with potential interactions.
Comprehensive Cultivation Guide
Medical Glue’s indica/sativa profile and Glue heritage make it approachable for intermediate growers and scalable for commercial rooms. Start with vigorous seedlings or rooted clones under 18–24 hours of light at 24–26 C days and 20–22 C nights. Maintain relative humidity around 60–70 percent during early veg, gradually stepping down to 55–60 percent as plants harden off. A PPFD of 300–500 µmol/m²/s for early veg and 600–800 µmol/m²/s for late veg supports compact, bushy development.
In flower, target 24–27 C daytime temperatures and 20–22 C nights, with relative humidity 40–50 percent for weeks 1–6 and 35–45 percent for weeks 7–10. Aim for PPFD of 900–1,100 µmol/m²/s without supplemental CO2, and up to 1,200–1,400 µmol/m²/s with CO2 enrichment at 900–1,200 ppm. Maintain VPD in the 1.2–1.5 kPa range in mid flower, edging toward 1.4–1.6 kPa late to mitigate botrytis risk. Consistent airflow with oscillating fans and robust intake/exhaust is essential for terpene preservation and disease prevention.
In soil, keep pH between 6.2–6.8; in coco and hydroponics, 5.8–6.2 is ideal. Electrical conductivity (EC) in veg commonly runs 1.2–1.8 mS/cm, increasing to 1.8–2.2 mS/cm in flower depending on cultivar appetite and medium. Taper nitrogen from week 3 of flower onward while holding phosphorus and potassium steady to support resin and calyx development. Many Glue hybrids respond well to balanced bloom formulas in the neighborhood of N-P-K ratios like 1–2–3 by mid flower.
Training strategies should emphasize even canopy development. Top or FIM in week 3–4 of veg, then employ low-stress training and trellising to spread branches laterally. Screen of Green (SCROG) methods can improve light distribution and yield density across the canopy. Aim to fill the net 70–80 percent before flipping to 12/12 to control stretch.
Flowering time is typically 8–10 weeks for Glue-leaning hybrids, with many growers harvesting around day 63–70 based on trichome maturity. Inspect trichomes with a jeweler’s loupe, targeting a field of mostly cloudy heads with 5–15 percent amber for a balanced effect. Earlier harvests skew more cerebral; later harvests increase body heaviness. Note that environmental consistency can shift the window by several days.
Yield is responsive to canopy management. Indoors, 450–600 grams per square meter is realistic under high-intensity LEDs with optimized environment and nutrition. Outdoors, well-grown plants in 100–200 liter containers can produce 500–1,000 grams per plant in favorable climates. Dense flowers require extra attention to airflow and dehumidification late season to avoid bud rot.
Integrated pest management (IPM) is non-negotiable. Perform weekly scouting for mites, thrips, and aphids, and deploy preventative biologicals like predatory mites and beneficial nematodes as needed. Keep floors clean, quarantine new clones, and sanitize tools between rooms. Powdery mildew risk drops with appropriate VPD, leaf defoliation in week 3 of flower, and strong airflow through the mid-canopy.
Watering discipline preserves root health and terpene expression. In soil and coco, allow partial drybacks to encourage oxygenation while avoiding severe wilt; aim for 10–20 percent runoff to prevent salt accumulation. Root-zone temperatures of 18–22 C support nutrient uptake and microbial activity. Excessively cold roots stunt growth and invite pathogens.
Nutrient supplementation should be data-driven. If using bottled nutrients, consider weekly runoff EC and pH checks to diagnose accumulation or lockout early. Supplement calcium and magnesium when running high-intensity LEDs, as demand often increases under stronger photon flux. Silica additions during veg can improve stem strength and stress tolerance, useful for heavy, resinous colas.
Pre-harvest flushing is a debated topic, but many growers reduce EC in the final 7–10 days to encourage the plant to draw down internal stores. Whether in hydro or coco, a taper to near-source water EC can reduce residual salts that might impact ash quality. In living soil, a simple water-only finish achieves a similar effect as microbe-mediated nutrient cycling slows. The goal is clean-burning flower with preserved terpene complexity.
For concentrate production, prioritize trichome integrity. Keep late-flower temperatures slightly cooler at lights-off to reduce terpene volatilization, and minimize handling during harvest. Phenotypes with abundant, well-formed capitate heads will produce better yields and quality in ice-water extraction. Track wash yields and bag sizes to identify the best phenos for solventless work.
Harvest, Drying, Curing, and Storage
After chop, hang whole plants or large branches for a slow dry targeting 60–64 F and 60–65 percent relative humidity. This 10–14 day window preserves volatile monoterpenes while allowing chlorophyll degradation and moisture equalization. Use gentle airflow that moves the room, not the flowers, and keep darkness continuous to protect cannabinoids and terpenes from light. Stem snap is a traditional readiness test, but a hygrometer in a curing jar provides objective confirmation.
Once jarred, aim for an internal jar relative humidity of 58–62 percent for flower. If readings exceed 65 percent, burp the jars daily for 10–15 minutes in a low-humidity room until stabilized. Water activity meters can provide precision; a target of 0.55–0.65 aw indicates a stable, mold-resistant cure. Most Glue-type cultivars benefit from a minimum 14–28 day cure, with aroma and smoothness improving week by week.
Long-term storage depends on temperature and oxygen control. Keep jars in the dark at 55–60 F for best preservation, and avoid frequent opening. Many users add inert gas purges or use vacuum-sealed glass-liner containers to limit oxidation. Properly stored Medical Glue can maintain strong aroma and potency for 6–12 months, with only gradual terpene loss over time.
Comparisons Within the Glue Family
Compared to archetypal Original Glue, Medical Glue is positioned for medical utility with a balanced indica/sativa designation and breeder emphasis on consistent relief. While Original Glue is often associated with heavy couch-lock at higher doses, Medical Glue’s selection likely aims for a more controlled ramp that suits daytime microdosing. Both share the resin-intensive hallmark and fuel-forward terpene signature, but Medical Glue may present slightly more approachable brightness from limonene and pinene. For some patients, that translates to a smoother early phase before body heaviness lands.
Relative to other Glue hybrids like Glueberry or New Glue offerings, Medical Glue stakes its identity on reliability and medicinal framing. In grow rooms, expect similar flowering windows and demand for dehumidification late in cycle due to dense buds. Aroma intensity should be on par with the best Glue examples, and total terpene levels above 2 percent are a credible target. For extractors, the sticky resin and well-formed heads that typify Glue lines remain a strong incentive.
If a patient has found GG4 too sedating or spiky at onset, Medical Glue may serve as a middle path with titratable effects. Conversely, those seeking maximum body melt can simply dose higher or extend session length to reach comparable depth. This flexibility is a functional advantage for patients whose daily needs vary between activity and rest. The shared Glue DNA keeps expectations aligned, while Sin City Seeds’ curation introduces a consistent medicinal tilt.
Consumer Guidance, Quality, and Safety
Patients new to Medical Glue should start low and go slow, particularly with oral routes. For inhalation, 1–2 small puffs, wait 10 minutes, then reassess is a simple, effective protocol. For oral products, begin with 1–2.5 mg THC, wait at least 2 hours, and avoid stacking doses too quickly. Consistency in timing, meal context, and device choice improves predictability.
Quality markers include clear COAs reporting cannabinoids, terpenes, and contaminant screens for pesticides, heavy metals, residual solvents, and microbial content. Look for batches with THC in the high teens to mid-20s and total terpenes above 1.5 percent to capture the intended Glue experience. Flower should be aromatic at arm’s length, slightly sticky, and springy rather than brittle. Ash color is an imperfect metric but can hint at clean cultivation and thorough cure when combined with other cues.
Safety fundamentals apply to all cannabis products. Do not drive or operate machinery while under the influence, and store products securely away from children and pets. Discuss cannabis use with your healthcare provider, especially if you take medications with potential interactions or have cardiovascular or psychiatric conditions. For those sensitive to THC, explore pairing with CBD or using terpene-forward aromatherapy as a lower-impact adjunct.
Breeder Notes and Availability
Medical Glue is credited to Sin City Seeds, and the indica/sativa heritage indicates a strain engineered for balanced outcomes. Sin City Seeds is known for distributing both regular and feminized lines across different releases, though availability can be cyclical and region-specific. Prospective growers should consult the breeder’s current catalog or trusted seed banks to verify the latest drop format. Because Glue-derived strains are popular, Medical Glue often moves quickly when it appears.
Phenotype hunting is recommended if multiple seeds are available. Look for plants with even internodal spacing, vigorous lateral growth, and notably sticky trichome heads by week 5–6 of flower. Aroma complexity during late veg scratch-and-sniff can foreshadow terpene output in bloom. Record-keeping across germination, training, and harvest will help identify keeper phenos for future runs.
For legal compliance, ensure that seeds and cultivation adhere to local laws and regulations. Many jurisdictions distinguish between possession, cultivation counts, and caregiver allowances for medical use. When in doubt, seek guidance from local regulatory resources or legal counsel. Responsible sourcing and adherence to regulations protect both patients and the broader community.
Data Snapshot and Practical Expectations
Potency expectations for Medical Glue should be set around THC 18–26 percent, CBD usually below 1 percent, and CBG in the 0.1–0.8 percent band. Total terpene content of 1.5–3.5 percent is a realistic benchmark for quality lots, translating to 15–35 mg/g of volatile aroma. Dominant terpenes typically include myrcene, beta-caryophyllene, limonene, humulene, and alpha-pinene, driving gas, pine, and pepper notes with citrus highlights. Inhalation onset occurs within minutes, with a 60–120 minute primary window and a relaxed, body-forward tail.
In the garden, anticipate an 8–10 week flowering period with indoor yields of 450–600 g/m² when properly trained and lit. Outdoors, 500–1,000 g per plant is feasible under favorable conditions with ample root volume and sun. Environmental targets that consistently deliver results include 24–27 C day temps in flower, 40–50 percent RH mid-flower, VPD around 1.2–1.5 kPa, and PPFD near 1,000 µmol/m²/s. pH control at 6.2–6.8 in soil and 5.8–6.2 in coco/hydro prevents common deficiencies and lockout.
For medical use, titration is key. New patients should start with 2–5 mg inhaled THC equivalents or 1–2.5 mg oral THC, increasing slowly based on response. Pairing with CBD can moderate peaks, and journaling dose, time, and effects builds a personalized playbook. Always coordinate with healthcare providers when integrating cannabis into a treatment plan.
